BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10070318)

  • 1. Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine.
    Arrieta O; Guevara P; Reyes S; Ortiz A; Rembao D; Sotelo J
    Eur J Cancer; 1998 Dec; 34(13):2101-6. PubMed ID: 10070318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma.
    Arrieta O; Guevara P; Tamariz J; Rembao D; Rivera E; Sotelo J
    Int J Exp Pathol; 2002 Apr; 83(2):99-104. PubMed ID: 12084046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suramin inhibits glioma cell proliferation in vitro and in the brain.
    Takano S; Gately S; Engelhard H; Tsanaclis AM; Brem S
    J Neurooncol; 1994; 21(3):189-201. PubMed ID: 7699415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinacrine enhances carmustine therapy of experimental rat glioma.
    Reyes S; Herrera LA; Ostrosky P; Sotelo J
    Neurosurgery; 2001 Oct; 49(4):969-73. PubMed ID: 11564260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suramin inhibits C6 glioma-induced angiogenesis in vitro.
    Coomber BL
    J Cell Biochem; 1995 Jun; 58(2):199-207. PubMed ID: 7545684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin.
    Soma MR; Baetta R; De Renzis MR; Mazzini G; Davegna C; Magrassi L; Butti G; Pezzotta S; Paoletti R; Fumagalli R
    Cancer Res; 1995 Feb; 55(3):597-602. PubMed ID: 7834630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of radiation on a model of malignant glioma invasion.
    Bauman GS; MacDonald W; Moore E; Ramsey DA; Fisher BJ; Amberger VR; Del Maestro RM
    J Neurooncol; 1999; 44(3):223-31. PubMed ID: 10720202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model.
    Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H
    Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiostatin suppresses malignant glioma growth in vivo.
    Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
    Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cotreatment with a novel phosphoinositide analogue inhibitor and carmustine enhances chemotherapeutic efficacy by attenuating AKT activity in gliomas.
    Van Meter TE; Broaddus WC; Cash D; Fillmore H
    Cancer; 2006 Nov; 107(10):2446-54. PubMed ID: 17041888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent treatment with BCNU and Gamma Knife radiosurgery in the rat malignant glioma model.
    Cho KT; Kim DG; Paek SH; Chung HT; Jung HW; Park HW
    J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):132-41. PubMed ID: 22628080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined growth-inhibitory responses and ultrastructural alterations produced by 1,3-bis(2-chloroethyl)-1-nitrosourea and dexamethasone in rat glioma cell cultures.
    Grasso RJ; Johnson CE; Boler RK; Moore NA
    Cancer Res; 1977 Feb; 37(2):585-94. PubMed ID: 832280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical effect of aspirin on the growth of C6 rat glioma and on time of development of ENU-induced tumors of the nervous system.
    Arrieta O; Guevara P; Reyes S; Palencia G; Rivera E; Sotelo J
    J Cancer Res Clin Oncol; 2001 Nov; 127(11):681-6. PubMed ID: 11710598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTK787/ZK222584, an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, decreases glioma growth and vascularization.
    Goldbrunner RH; Bendszus M; Wood J; Kiderlen M; Sasaki M; Tonn JC
    Neurosurgery; 2004 Aug; 55(2):426-32; discussion 432. PubMed ID: 15271251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic activity of endostatin inhibits C6 glioma growth.
    Peroulis I; Jonas N; Saleh M
    Int J Cancer; 2002 Feb; 97(6):839-45. PubMed ID: 11857365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of growth factor antagonists on neoplastic and normal prostatic cells.
    Morton RA; Isaacs JT; Isaacs WB
    Prostate; 1990; 17(4):327-36. PubMed ID: 2251224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
    Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
    Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas.
    Farhadi MR; Capelle HH; Erber R; Ullrich A; Vajkoczy P
    J Neurosurg; 2005 Feb; 102(2):363-70. PubMed ID: 15739567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone inhibits glioma-induced formation of capillary like structures in vitro and angiogenesis in vivo.
    Wolff JE; Mölenkamp G; Hotfilder M; Laterra J
    Klin Padiatr; 1997; 209(4):275-7. PubMed ID: 9293462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies.
    Lin SH; Kleinberg LR
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):343-59. PubMed ID: 18366283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.